Quince Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
QNCX Nasdaq 8731 https://quincetx.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Quince Therapeutics Inc

Quince Therapeutics Provides Business Update and Reports Fourth Quarter and Fiscal 2023 Financial Results - Apr 1st, 2024 11:00 am
The Zacks Analyst Blog Highlights Quince Therapeutics and XBiotech - Mar 8th, 2024 9:40 am
Quince Therapeutics Launches Scientific Advisory Board - Feb 22nd, 2024 12:00 pm
Quince Therapeutics Appoints Former Reata Pharmaceuticals Chief R&D Officer Dr. Rajiv Patni to its Board of Directors - Feb 15th, 2024 12:00 pm
Quince Therapeutics to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference - Feb 7th, 2024 9:05 pm
Quince Therapeutics to Participate at Investor Events in January 2024 - Jan 4th, 2024 9:05 pm
10 Best Debt Free Penny Stocks To Buy Now - Dec 4th, 2023 12:21 pm
Quince Therapeutics Completes Acquisition of EryDel S.p.A. - Oct 23rd, 2023 11:00 am
U.S. FDA Partial Clinical Hold Lifted on IND for EryDel’s Lead Phase 3 Asset EryDex for the Treatment of Ataxia-Telangiectasia - Sep 28th, 2023 8:05 pm
Quince Therapeutics Appoints Dr. Charles S. Ryan as President - Sep 6th, 2023 11:00 am
Sidoti Events, LLC’s Virtual August Micro-Cap Conference - Aug 15th, 2023 2:20 pm
Quince Therapeutics to Present at Sidoti Virtual Investor Conference on August 17, 2023 - Aug 10th, 2023 8:05 pm
Quince Therapeutics to Acquire EryDel SpA and its Phase 3 Asset Targeting Ataxia-Telangiectasia with No Currently Approved Treatments and Estimated $1+ Billion Peak Sales Opportunity - Jul 24th, 2023 11:00 am
Echo Lake Capital Increase Offer to Acquire Quince Therapeutics, Inc. - Jul 13th, 2023 12:00 pm
Echo Lake Criticizes Quince Therapeutics Board for Enriching Themselves While Destroying Significant Shareholder Value - Jun 6th, 2023 12:00 pm